The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Parecoxib Sodium Market Research Report 2025

Global Parecoxib Sodium Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1900822

No of Pages : 86

Synopsis
Parecoxib Sodium (CAS 198470-85-8), C19H17N2NaO4S, the formula weight is 392.40, and its form is white solid.
The global Parecoxib Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Parecoxib sodium is used for short-term treatment of postoperative pain.
This report aims to provide a comprehensive presentation of the global market for Parecoxib Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parecoxib Sodium.
Report Scope
The Parecoxib Sodium market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parecoxib Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parecoxib Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parecoxib Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parecoxib Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Parecoxib Sodium Market Overview
1.1 Product Overview and Scope of Parecoxib Sodium
1.2 Parecoxib Sodium Segment by Type
1.2.1 Global Parecoxib Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Parecoxib Sodium Segment by Application
1.3.1 Global Parecoxib Sodium Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Parecoxib Sodium Market Size Estimates and Forecasts
1.4.1 Global Parecoxib Sodium Revenue 2019-2030
1.4.2 Global Parecoxib Sodium Sales 2019-2030
1.4.3 Global Parecoxib Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Parecoxib Sodium Market Competition by Manufacturers
2.1 Global Parecoxib Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Parecoxib Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Parecoxib Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Parecoxib Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parecoxib Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parecoxib Sodium, Product Type & Application
2.7 Parecoxib Sodium Market Competitive Situation and Trends
2.7.1 Parecoxib Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parecoxib Sodium Players Market Share by Revenue
2.7.3 Global Parecoxib Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parecoxib Sodium Retrospective Market Scenario by Region
3.1 Global Parecoxib Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Parecoxib Sodium Global Parecoxib Sodium Sales by Region: 2019-2030
3.2.1 Global Parecoxib Sodium Sales by Region: 2019-2024
3.2.2 Global Parecoxib Sodium Sales by Region: 2025-2030
3.3 Global Parecoxib Sodium Global Parecoxib Sodium Revenue by Region: 2019-2030
3.3.1 Global Parecoxib Sodium Revenue by Region: 2019-2024
3.3.2 Global Parecoxib Sodium Revenue by Region: 2025-2030
3.4 North America Parecoxib Sodium Market Facts & Figures by Country
3.4.1 North America Parecoxib Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Parecoxib Sodium Sales by Country (2019-2030)
3.4.3 North America Parecoxib Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Parecoxib Sodium Market Facts & Figures by Country
3.5.1 Europe Parecoxib Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Parecoxib Sodium Sales by Country (2019-2030)
3.5.3 Europe Parecoxib Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parecoxib Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Parecoxib Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Parecoxib Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Parecoxib Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Parecoxib Sodium Market Facts & Figures by Country
3.7.1 Latin America Parecoxib Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Parecoxib Sodium Sales by Country (2019-2030)
3.7.3 Latin America Parecoxib Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parecoxib Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Parecoxib Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Parecoxib Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Parecoxib Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Parecoxib Sodium Sales by Type (2019-2030)
4.1.1 Global Parecoxib Sodium Sales by Type (2019-2024)
4.1.2 Global Parecoxib Sodium Sales by Type (2025-2030)
4.1.3 Global Parecoxib Sodium Sales Market Share by Type (2019-2030)
4.2 Global Parecoxib Sodium Revenue by Type (2019-2030)
4.2.1 Global Parecoxib Sodium Revenue by Type (2019-2024)
4.2.2 Global Parecoxib Sodium Revenue by Type (2025-2030)
4.2.3 Global Parecoxib Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Parecoxib Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Parecoxib Sodium Sales by Application (2019-2030)
5.1.1 Global Parecoxib Sodium Sales by Application (2019-2024)
5.1.2 Global Parecoxib Sodium Sales by Application (2025-2030)
5.1.3 Global Parecoxib Sodium Sales Market Share by Application (2019-2030)
5.2 Global Parecoxib Sodium Revenue by Application (2019-2030)
5.2.1 Global Parecoxib Sodium Revenue by Application (2019-2024)
5.2.2 Global Parecoxib Sodium Revenue by Application (2025-2030)
5.2.3 Global Parecoxib Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Parecoxib Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Parecoxib Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Parecoxib Sodium Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sailong Pharma
6.2.1 Sailong Pharma Corporation Information
6.2.2 Sailong Pharma Description and Business Overview
6.2.3 Sailong Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sailong Pharma Parecoxib Sodium Product Portfolio
6.2.5 Sailong Pharma Recent Developments/Updates
6.3 Chiarai Tianqing
6.3.1 Chiarai Tianqing Corporation Information
6.3.2 Chiarai Tianqing Description and Business Overview
6.3.3 Chiarai Tianqing Parecoxib Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chiarai Tianqing Parecoxib Sodium Product Portfolio
6.3.5 Chiarai Tianqing Recent Developments/Updates
6.4 Qilu Pharma
6.4.1 Qilu Pharma Corporation Information
6.4.2 Qilu Pharma Description and Business Overview
6.4.3 Qilu Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Pharma Parecoxib Sodium Product Portfolio
6.4.5 Qilu Pharma Recent Developments/Updates
6.5 Kelun Pharma
6.5.1 Kelun Pharma Corporation Information
6.5.2 Kelun Pharma Description and Business Overview
6.5.3 Kelun Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kelun Pharma Parecoxib Sodium Product Portfolio
6.5.5 Kelun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parecoxib Sodium Industry Chain Analysis
7.2 Parecoxib Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parecoxib Sodium Production Mode & Process
7.4 Parecoxib Sodium Sales and Marketing
7.4.1 Parecoxib Sodium Sales Channels
7.4.2 Parecoxib Sodium Distributors
7.5 Parecoxib Sodium Customers
8 Parecoxib Sodium Market Dynamics
8.1 Parecoxib Sodium Industry Trends
8.2 Parecoxib Sodium Market Drivers
8.3 Parecoxib Sodium Market Challenges
8.4 Parecoxib Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’